Elliot Campbell
Papers
1
Total Citations
120
H-Index
1
About
Elliot Campbell is a leading figure in structural and molecular biology, whose work has revolutionized the production of renewable, high-quality research reagents. His primary research focuses on developing high-throughput platforms for generating recombinant antibodies, particularly against challenging targets like folded proteins and transcription factors. Campbell’s landmark 2015 paper, which has garnered over 120 citations, introduced an industrialized pipeline for creating validated recombinant antibodies for 346 transcription factors. This work directly addressed a critical bottleneck in biology and medicine: the reliance on non-renewable commercial antibody sources. By providing a permanent, sequence-defined resource, Campbell’s platform has enabled more reproducible and scalable studies in gene regulation and cellular signaling. His contributions are foundational for researchers seeking robust tools for proteomics and drug discovery, cementing his reputation as an innovator in antibody engineering and functional genomics.
Research Focus
Key Achievements
Top Papers
- 1A High Through-put Platform for Recombinant Antibodies to Folded Proteins120 citations · 2015